Jyong Biotech annual ebitda
2022
2023
2024
2025
Jyong Biotech EBITDA Growth & History (MENS)
Jyong Biotech's calculated EBITDA was −$2.5M for fiscal 2025.
View full Jyong Biotech company overviewJyong Biotech annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$2.5M | −$571,000 | — |
| 2024 | 2024-12-31 | −$1.9M | $734,000 | — |
| 2023 | 2023-12-31 | −$2.7M | $3.1M | — |
| 2022 | 2022-12-31 | −$5.7M | — | — |
Jyong Biotech ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Jyong Biotech's ebitda increased from −$5.7M to −$2.5M, a change of $3.2M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jyong Biotech source filings ↗